Amgen Financial Statements
Amgen Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
| Annual Report | Company Web Site |
| Investor Relations | Company Web Site |
Amgen Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 14,771.0 | 14,268.0 | 12,430.0 |
| Gross Profit ($ mil.) | 12,223.0 | 12,173.0 | 10,348.0 |
| Operating Income ($ mil.) | 3,980.0 | 3,840.0 | 4,848.0 |
| Total Net Income ($ mil.) | 3,166.0 | 2,950.0 | 3,674.0 |
| Diluted EPS (Net Income) | 2.82 | 2.48 | 2.93 |
Amgen Quarterly Statements
| Quarter Ending Mar 08 | Quarter Ending Dec 07 | Quarter Ending Sep 07 | |
|---|---|---|---|
| Revenue ($ mil.) | 3,613.0 | 3,745.0 | 3,611.0 |
| Gross Profit ($ mil.) | 3,067.0 | 3,139.0 | 2,819.0 |
| Operating Income ($ mil.) | 1,415.0 | 1,057.0 | 393.0 |
| Total Net Income ($ mil.) | 1,136.0 | 835.0 | 201.0 |
| Diluted EPS (Net Income) | 1.04 | 0.76 | 0.22 |
Amgen Stock Quote & Chart
| 07/23/08 15:00:16 EST •
NASDAQ •
53.92
•
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
Amgen Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 3.90 | 3.82 | 1.51 |
| Price/Earnings Ratio | 18.03 | 15.93 | 15.01 |
| Price/Book Ratio | 3.00 | 2.76 | 1.44 |
| Price/Cash Flow Ratio | 9.41 | 11.64 | 9.38 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Amgen Financial Ratios
Amgen Competitive Intelligence
| Johnson & Johnson | Novartis | Sanofi-Aventis | |
|---|---|---|---|
| Annual Sales ($ mil.) | 61,095.0 | 38,947.0 | 43,019.0 |
| Employees | -- | 98,200 | 99,495 |
| Market Cap ($ mil.) | 190,679.1 | -- | -- |
Competitive Landscape




